You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DIMETANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dimetane patents expire, and when can generic versions of Dimetane launch?

Dimetane is a drug marketed by Wyeth Cons, Robins Ah, and Wyeth Ayerst. and is included in three NDAs.

The generic ingredient in DIMETANE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIMETANE?
  • What are the global sales for DIMETANE?
  • What is Average Wholesale Price for DIMETANE?
Summary for DIMETANE
US Patents:0
Applicants:3
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 72
Patent Applications: 4,474
DailyMed Link:DIMETANE at DailyMed
Drug patent expirations by year for DIMETANE

US Patents and Regulatory Information for DIMETANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-010 Jun 10, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Robins Ah DIMETANE-DX brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 019279-001 Aug 24, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-011 Jun 10, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Cons DIMETANE brompheniramine maleate TABLET;ORAL 010799-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst DIMETANE-TEN brompheniramine maleate INJECTABLE;INJECTION 011418-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.